SWIM
CTXR icon

Smallwood Wealth Investment Management’s Citius Pharmaceuticals CTXR Stock Holding History

Smallwood Wealth Investment Management’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72 Hold
120
– – ﹤0.01% 499
2026
Q1 		$108 Hold
120
– – ﹤0.01% 487
2025
Q4 		$93 Hold
120
– – ﹤0.01% 479
2025
Q3 		$148 Hold
120
– – ﹤0.01% 481
2025
Q2 		$190 Hold
120
– – ﹤0.01% 526
2025
Q1 		$178 Buy
+120
New +$287 ﹤0.01% 469

Other funds holding CTXR

MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
BW
BostonPremier Wealth Hanover, Massachusetts $235M AUM 31.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Smallwood Wealth Investment Management's CTXR Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 120 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Smallwood Wealth Investment Management first reported a position in CTXR in Q1 2025 and has held it in 6 quarters since. The position peaked at $190 in Q2 2025. 9 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Smallwood Wealth Investment Management held 120 shares of Citius Pharmaceuticals worth $72 as of Q2 2026.
  • Smallwood Wealth Investment Management left its Citius Pharmaceuticals share count unchanged in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #499 holding.
  • Smallwood Wealth Investment Management first reported a position in Citius Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Smallwood Wealth Investment Management's Citius Pharmaceuticals position peaked at $190 in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.